Legal Opinion

Senju Pharmaceutical Co. v. Lupin Ltd.

District Court, D. New Jersey

Decided November 18, 2015No. Civil Action Nos. 14-667 (JBS/KMW), 14-4149 (JBS/KMW), 14-5144 (JBS/KMW), 15-335 (JBS/KMW), 14-6893 (JBS/KMW), 15-3240 (JBS/KMW)PublishedCited by 2 opinions

1Opinion of the Court

MARKMAN OPINION

SIMANDLE, Chief Judge:

I. INTRODUCTION

Plaintiffs Senju Pharmaceútical Co., Ltd., Bausch & Lomb Inc., and Bausch & Lomb Pharma Holdings Corp. (collectively, “Plaintiffs”) brought these various patent infringement actions under the Hatch-Waxman Act, 35 U.S.C. §§ 271, 281, against Defendants Lupin, Ltd., Lupin Pharmaceuticals, Inc., Innopharma Licensing, Inc., Innopharma Licensing, LLC, In-nopharma, Inc., and Innopharma, LLC (collectively, “Defendants”) concerning Defendants’ submissions of abbreviated new drug applications (“ANDAs”) seeking FDA approval to market a generic version…

2Cases cited23 opinions

  1. MARKMAN Et Al. v. WESTVIEW INSTRUMENTS, INC., Et Al.Supreme Court of the United States · 1996
  2. Edward H. Phillips v. Awh Corporation, Hopeman Brothers, Inc., and Lofton Corporation, Defendants-CrossCourt of Appeals for the Federal Circuit · 2006
  3. Vitronics Corporation v. Conceptronic, Inc.Court of Appeals for the Federal Circuit · 1996
  4. Nautilus, Inc. v. Biosig Instruments, Inc.Supreme Court of the United States · 2014
  5. Ccs Fitness, Inc. v. Brunswick Corporation and Its Division Life FitnessCourt of Appeals for the Federal Circuit · 2002

18 more not listed; retrieve them via the Exa API.

3Cited by2 opinions

  1. Ingenus Pharmaceuticals, LLC v. Nexus Pharmaceuticals, Inc.District Court, N.D. Illinois · 2025
  2. VIFOR (INTERNATIONAL) AG v. MYLAN LABORATORIES LTD.District Court, D. New Jersey · 2021

Showing a preview — retrieve the full document via the Exa API.

Powered by the Exa API